Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,482 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A streamlined, resource-efficient immunoprecipitation-mass spectrometry method for quantifying plasma amyloid-β biomarkers in Alzheimer's disease.
Karikari T, Chen Y, Zeng X, Olvera-Rojas M, Sehrawat A, Lafferty T, Pascoal T, Villemagne V, Solis-Urra P, Triviño-Ibañez E, Gómez-Rí M, Cohen A, Ikonomovic M, Esteban-Cornejo I, Erickson K, Lopez O, Yates N. Karikari T, et al. Among authors: lopez o. Res Sq [Preprint]. 2024 Sep 2:rs.3.rs-4947448. doi: 10.21203/rs.3.rs-4947448/v1. Res Sq. 2024. PMID: 39281858 Free PMC article. Preprint.
Synaptic Proteome Compensation and Resilience to Psychosis in Alzheimer's Disease.
Krivinko JM, Erickson SL, Ding Y, Sun Z, Penzes P, MacDonald ML, Yates NA, Ikonomovic MD, Lopez OL, Sweet RA, Kofler J. Krivinko JM, et al. Am J Psychiatry. 2018 Oct 1;175(10):999-1009. doi: 10.1176/appi.ajp.2018.17080858. Epub 2018 Jul 19. Am J Psychiatry. 2018. PMID: 30021459 Free PMC article.
Genetic risk for attention-deficit/hyperactivity disorder predicts cognitive decline and development of Alzheimer's disease pathophysiology in cognitively unimpaired older adults.
Leffa DT, Ferrari-Souza JP, Bellaver B, Tissot C, Ferreira PCL, Brum WS, Caye A, Lord J, Proitsi P, Martins-Silva T, Tovo-Rodrigues L, Tudorascu DL, Villemagne VL, Cohen AD, Lopez OL, Klunk WE, Karikari TK, Rosa-Neto P, Zimmer ER, Molina BSG, Rohde LA, Pascoal TA; Alzheimer’s Disease Neuroimaging Initiative. Leffa DT, et al. Mol Psychiatry. 2023 Mar;28(3):1248-1255. doi: 10.1038/s41380-022-01867-2. Epub 2022 Dec 8. Mol Psychiatry. 2023. PMID: 36476732
Astrocyte reactivity influences the association of amyloid-β and tau biomarkers in preclinical Alzheimer's disease.
Pascoal T, Bellaver B, Povala G, Ferreira P, Ferrari-Souza JP, Leffa D, Lussier F, Benedet A, Ashton N, Triana-Baltzerz G, Kolbzh H, Tissot C, Therriault J, Servaes S, Stevenson J, Rahmouni N, Lopez O, Tudorascu D, Villemagne V, Ikonomovic M, Gauthier S, Zimmer E, Zetterberg H, Blennow K, Aizenstein H, Klunk W, Snitz B, Maki P, Thurston R, Cohen A, Ganguli M, Karikari T, Rosa-Neto P. Pascoal T, et al. Among authors: lopez o. Res Sq [Preprint]. 2023 Feb 1:rs.3.rs-2507179. doi: 10.21203/rs.3.rs-2507179/v1. Res Sq. 2023. Update in: Nat Med. 2023 Jul;29(7):1775-1781. doi: 10.1038/s41591-023-02380-x PMID: 36778243 Free PMC article. Updated. Preprint.
Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer's disease.
Bellaver B, Povala G, Ferreira PCL, Ferrari-Souza JP, Leffa DT, Lussier FZ, Benedet AL, Ashton NJ, Triana-Baltzer G, Kolb HC, Tissot C, Therriault J, Servaes S, Stevenson J, Rahmouni N, Lopez OL, Tudorascu DL, Villemagne VL, Ikonomovic MD, Gauthier S, Zimmer ER, Zetterberg H, Blennow K, Aizenstein HJ, Klunk WE, Snitz BE, Maki P, Thurston RC, Cohen AD, Ganguli M, Karikari TK, Rosa-Neto P, Pascoal TA. Bellaver B, et al. Nat Med. 2023 Jul;29(7):1775-1781. doi: 10.1038/s41591-023-02380-x. Epub 2023 May 29. Nat Med. 2023. PMID: 37248300 Free PMC article.
Implementation and Assessment of Tau Thresholds in Non-Demented Individuals as Predictors of Cognitive Decline in Tau Imaging Studies.
Gogola A, Cohen AD, Snitz B, Minhas D, Tudorascu D, Ikonomovic MD, Shaaban CE, Doré V, Matan C, Bourgeat P, Mason NS, Leuzy A, Aizenstein H, Mathis CA, Lopez OL, Lopresti BJ, Villemagne VL; Alzheimer’s Disease Neuroimaging Initiative. Gogola A, et al. J Alzheimers Dis. 2024;100(s1):S75-S92. doi: 10.3233/JAD-240543. J Alzheimers Dis. 2024. PMID: 39121123
1,482 results